Uenaka; Toshimitsu
Patent Applications and Registrations
Patent applications and USPTO patent grants for Uenaka; Toshimitsu.The latest application filed is for "eribulin-based antibody-drug conjugates and methods of use".
- Uenaka; Toshimitsu - West Chester PA
- Uenaka; Toshimitsu - Tsukuba JP
- Uenaka; Toshimitsu - Ibaraki N/A JP
| Patent | Date |
|---|---|
| Eribulin-based Antibody-drug Conjugates And Methods Of Use App 20200297860 - Albone; Earl F. ; et al. | 2020-09-24 |
| Eribulin-based antibody-drug conjugates and methods of use Grant 10,548,986 - Albone , et al. Fe | 2020-02-04 |
| Eribulin-based antibody-drug conjugates and methods of use Grant 10,322,192 - Albone , et al. | 2019-06-18 |
| Eribulin-based Antibody-drug Conjugates And Methods Of Use App 20180193478 - Albone; Earl F. ; et al. | 2018-07-12 |
| Eribulin-based Antibody-drug Conjugates And Methods Of Use App 20170252458 - Albone; Earl F ; et al. | 2017-09-07 |
| Use Of Eribulin And Mtor Inhibitors As Combination Therapy For The Treatment Of Cancer App 20170071903 - FUNAHASHI; Yasuhiro ; et al. | 2017-03-16 |
| Method for assay on the effect of vascularization inhibitor Grant 9,006,240 - Uenaka , et al. April 14, 2 | 2015-04-14 |
| Method for assay on the effect of vascularization inhibitor Grant 8,969,344 - Matsui , et al. March 3, 2 | 2015-03-03 |
| Method For Assay On The Effect Of Vascularization Inhibitor App 20130085152 - Matsui; Junji ; et al. | 2013-04-04 |
| Method For Assay On The Effect Of Vascularization Inhibitor App 20100092490 - Uenaka; Toshimitsu ; et al. | 2010-04-15 |
| Bioactive substance Grant 7,667,052 - Mizui , et al. February 23, 2 | 2010-02-23 |
| Assay Method to Predict Sensitivity of Cancer Cell to Anticancer Drug App 20080280288 - Uenaka; Toshimitsu ; et al. | 2008-11-13 |
| Novel bioactive substance App 20060079572 - Mizui; Yoshiharu ; et al. | 2006-04-13 |
| Physiologically active substances Grant 7,026,352 - Mizui , et al. April 11, 2 | 2006-04-11 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 